Dublin, Dec. 14, 2017 (GLOBE NEWSWIRE) -- The "Gastrointestinal / GI Stent Market by Type, Materia, Disease, End User - Global Forecast to 2022" report has been added to Research and Markets' offering.

The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period.

Market growth can be attributed to the growth in the geriatric population, increasing preference for minimally invasive surgeries, rising prevalence of GI cancers and other digestive diseases, and changing lifestyles.

The report analyzes the global gastrointestinal stent market, by product, material, disease type, end user, and region. Based on product, the biliary stents segment accounted for the largest share of global market in 2016. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as the growth in the number of surgical procedures for the treatment of these diseases.

The major complications associated with the implementation of gastrointestinal stents include stent misplacement or displacement, bleeding, obstruction, perforation, stent fracture or collapse, and infection. Bacterial colonization is a major factor leading to plastic stent occlusion, which results in sludge formation and luminal obstruction. Covered gastrointestinal stents generally prevent obstruction from tumor ingrowth with a covering membrane but have a higher migration rate. These complications associated with gastrointestinal stenting are limiting their adoption.

Boston Scientific Corporation (US) dominated the global gastrointestinal stent market in 2016. The company focuses on increasing its share in the market by strategically investing in R&D activities. For instance, in 2016, the company invested USD 920 million in R&D, as compared to USD 876 million in 2015. The company's focus on improving its speed and performance through new capabilities, processes, and advanced innovative technologies; its expanding commercial presence globally; and its cost-reduction initiatives help it to accelerate its growth in the market. In 2016, the company's revenue reported a growth of 12% as compared to the previous year. The company is also focusing on expanding its business in emerging countries. It reported a growth of 22% in its annual revenue in China, which is one of the largest emerging markets in the developing world.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Gastrointestinal Stent Market: Overview
4.2 Asia Pacific: Gastrointestinal Cancer Stents Market, By Product and Country
4.3 Global Market, By Country
4.4 Global Market, By Disease Type
4.5 Regional Mix: Global Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Gastrointestinal Cancers and Other Digestive Diseases
5.2.1.2 Increasing Geriatric Population
5.2.1.3 Growing Preference for Minimally Invasive Procedures
5.2.1.4 Changing Lifestyles
5.2.2 Restraint
5.2.2.1 Complications Associated With Gastrointestinal Stent Implementation
5.2.3 Opportunities
5.2.3.1 Development of Biodegradable and Drug-Eluting Gastrointestinal Stents
5.2.3.2 Emerging Markets
5.3 Reimbursement Scenario in the US
5.4 Regulatory Analysis

6 Gastrointestinal Stent Market, By Product
6.1 Introduction
6.2 Biliary Stents
6.3 Colonic Stents
6.4 Duodenal Stents
6.5 Pancreatic Stents
6.6 Esophageal Stents

7 Gastrointestinal Stent Market, By Material
7.1 Introduction
7.2 Self-Expanding Metal Stents
7.2.1 Nitinol Stents
7.2.2 Stainless Steel Stents
7.2.3 Other Metal Stents
7.3 Plastic Stents

8 Gastrointestinal Stent Market, By Disease Type
8.1 Introduction
8.2 Biliary Diseases
8.3 Gastrointestinal Cancer
8.3.1 Colorectal Cancer
8.3.2 Pancreatic Cancer
8.3.3 Stomach Cancer
8.3.4 Esophageal Cancer
8.4 Inflammatory Bowel Diseases

9 Gastrointestinal Stent Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Ambulatory Surgery Centers

10 Gastrointestinal Stent Market, By Region

11 Competitive Landscape

12 Company Profiles

• Becton, Dickinson and Company
• Boston Scientific
• C.R. Bard
• Cantel Medical
• Conmed
• Cook Group
• Diagmed Healthcare
• Ella-CS
• Endo-Flex
• M.I. Tech
• Merit Medical Systems
• Micro-Tech (Nanjing)
• Olympus
• Taewoong Medical

For more information about this report visit https://www.researchandmarkets.com/research/zdthvq/global?w=12

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Stents